Anticoagulation in atrial fibrillation: what is certain and what is to come
Thromboembolism is the major complication in atrial fibrillation, prevention of which constitutes a major challenge in the modern treatment of this common arrhythmia. Treatment with oral anticoagulation is considered the ‘gold standard’, although several controversial issues have been raised concern...
Saved in:
Published in: | European heart journal supplements Vol. 5; no. suppl-H; pp. H45 - H50 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford University Press
01-09-2003
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Thromboembolism is the major complication in atrial fibrillation, prevention of which constitutes a major challenge in the modern treatment of this common arrhythmia. Treatment with oral anticoagulation is considered the ‘gold standard’, although several controversial issues have been raised concerning its use in all subgroups of patients affected by atrial fibrillation. In this review, the ‘state of the art’ treatment strategies in this important and potentially lethal clinical complication are discussed, with particular attention given to issues that remain unresolved. Finally, current proven and accepted therapeutic approaches are presented. |
---|---|
Bibliography: | istex:B666964DD6C2FD4795446D1DC3F43AB375CD5609 local:0390023X.H45 PII:S1520765X0390023X Dr Giovanni Quinto Villani, Divisione di Cardiologia, Ospedale Civile, Via Taverna 49, 29100 Piacenza, Italy ark:/67375/HXZ-HFJVBHN3-1 |
ISSN: | 1520-765X |
DOI: | 10.1016/S1520-765X(03)90023-X |